Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing

Digital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Institute||Digital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX: Genetics and Ethics database hosted by Georgetown University